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Pittsburgh, Pa; and Seoul, Korea
Objective: Secondary interventions after endovascular aneurysm repair (EVAR) remain a concern. Most are simple
catheter-based procedures, but in some instances, open conversions (OCs) are required and carry a worse outcome. We
reviewed our experience to characterize these OCs.
Methods: A retrospective review was conducted of all patients who underwent an OC after a previous EVAR for an
aneurysm-related indication from 2001 to 2010. Clinical outcomes are reported.
Results:Data were reviewed for 44 patients (77%men) with a mean age of 74 years (range, 55-90 years). The average time
from EVAR to the first OCwas 45 months (range, 2-190 months). In six patients (14%), the initial EVARwas at another
institution. The endografts used were Ancure in 16, Excluder in 13, AneuRx in eight, Zenith in three, Lifepath in one,
Renu in one, and undetermined in two. Twenty-two patients had previously undergone a total of 32 endovascular
reinterventions before their index OC. Indications for OC were aneurysm expansion in 28 (64%), rupture in 12 (27%),
and infection in four (9%). The endograft was preserved in situ in 10 patients (23%). Explantation was partial in 18 (41%)
or complete in 16 (36%). Endograft preservation was used for type II endoleak in all but one patient by selective ligation
of the culprit arteries (lumbar in four, inferior mesenteric artery in five, and middle sacral in one). Proximal neck banding
was performed in one type Ia endoleak. Overall morbidity was 55%, and mortality was 18%. No deaths occurred in a
subgroup of patients who underwent endograft preservation with selective ligation of culprit vessels for type II endoleak.
Intraoperative complications included bowel injury in two, bleeding in two, splenectomy in one, and ureteral injury in
one. At a mean follow-up of 20 months, two patients underwent additional procedures after the index OC: one after
endograft preservation and one after partial explantation. None of the patients who underwent elective OC with
endograft preservation required subsequent endograft explantation.
Conclusions: Most OCs after EVAR are associated with significant morbidity and mortality, except when electively
treating an isolated type II endoleak with ligation of branches and preservation of the endograft. ( J Vasc Surg 2012;55:
1562-9.)
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iEndovascular aneurysm repair (EVAR) has become the
preferred treatment for infrarenal abdominal aortic aneu-
rysms (AAA). Currently, 60% of infrarenal AAAs are
treated by endovascular means. This is due to superior
short-term outcomes with EVAR compared with open
repair.1-3 However, long-term surveillance with timely re-
intervention, when indicated, is critical to ensure long-term
success.
Even though most reinterventions after EVAR are per-
formed by endovascular means, a small proportion of pa-
tients (0.9% to 4.5%) will require an open intervention.4-8
The results of open conversions (OCs) for aneurysm repair
after EVAR are limited to case series, and comparison of
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1562utcomes is difficult due to heterogeneous indications and
reatment strategies. This study reports a single center’s
xperience with delayed (30 days) OC after EVAR.
ETHODS
Medical records of patients who underwent delayed
C after EVAR at the University of Pittsburgh Medical
enter (UPMC) and the Department of Veterans Affairs
ittsburgh Healthcare System (VAPHS) during a 10-year
eriod between January 2001 and December 2010 were
eviewed. Institutional Review Board approval was ob-
ained from both institutions.
OC was defined as any transperitoneal or retroperito-
eal intervention for aneurysm-related or graft-related
omplications, with or without endograft explantation.
nly delayed OCs that were performed 30 days of the
ndex EVAR were included in this study. The techniques
sed included total or partial explantation of the endograft,
omplete preservation of the endograft with ligation of
ulprit arterial branches accountable for the endoleak, and
ortic neck banding.
Patient demographics and comorbidities were noted.
he indications and the operative reports of the initial
VAR, when available, were reviewed. Patients were mon-
tored at 1 and 6months after EVAR and then yearly. More
requent follow-up was at the discretion of the operating
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Volume 55, Number 6 Chaar et al 1563surgeon. Clinic notes and imaging studies were reviewed
for secondary interventions after EVAR.
Before OC was performed, an endovascular approach
was attempted first to treat patients with asymptomatic
aneurysm growth and in select cases of rupture. When
endovascular means failed, the decision to proceed with
OC was based on the risks of an OC weighed against the
risks of rupture, depending on the size of the aneurysm and
the type of endoleak. In general, a type I endoleak was
treated when identified regardless of aneurysm size and a
type II endoleak when associated with continued aneurysm
growth6 cm. The decision to convert was individualized
in each case after careful assessment of the patient’s clinical
picture and overall risks.
The indications for OC were divided into three catego-
ries: aneurysm growth, rupture, and infection. OCs per-
formed for asymptomatic aneurysm growth were per-
formed electively. The OCs performed for rupture,
infection, including fistula, and symptomatic aneurysm ex-
pansion were performed urgently or emergently and classi-
fied as nonelective OCs.
Operative details, including surgical approach (trans-
peritoneal or retroperitoneal), operative time, cross-clamp
site, estimated blood loss, and mode of reconstruction,
were recorded. The type of endoleak found on follow-up or
detected at OC was noted to elucidate the mechanism of
failure. Intraoperative and postoperative complications
were recorded. Operative mortality was defined as death if
30 days or in-hospital death if 30 days. Survival data
were obtained frommedical records and the Social Security
Death Index. Results are expressed as mean  standard
deviation for continuous data and as frequency and per-
centage for categorical data.
The outcomes for patients who underwent elective
OCs were compared with patients who had nonelective
OCs. Baseline patient characteristics were compared using
Table I. Baseline patient characteristics undergoing electiv
Variablesa Total
Total patients 44
Age, years 74  8
Male sex 34 (77)
Comorbidities
Hypertension 40 (91)
Hyperlipidemia 25 (57)
Diabetes 9 (20)
Coronary artery disease 23 (52)
CABG 12 (27)
Renal insufficiency 6 (14)
Cerebrovascular disease 7 (16)
COPD 13(30)
Smoking 24(54)
Medications
-Blocker 30 (68)
Statin 22 (50)
CABG, Coronary artery bypass grafting; COPD, chronic obstructive pulmo
aData are presented as number (%), except for age, which is mean  standathe t-test or Wilcoxon rank sum test for quantitative vari- tbles between two groups and analysis of variance F test or
ruskal-Wallis rank sum test for comparisons among more
han two groups. The Fisher exact test was used for com-
arison of categorical baseline characteristics. Survival rates
ere calculated using the Kaplan-Meier method, using
og-rank test for comparison of Kaplan-Meier curves. Anal-
ses were performed with the R 2.11.1 statistical software
http://www.r-project.org) under the significance level
f 0.05.
ESULTS
The cohort undergoing delayed OCs after EVAR com-
rised 44 patients (77% men) who were a mean age of 74
ears (range, 55-90 years). Patient demographics and co-
orbidities are detailed in Table I. Average time from
VAR to OC was 45 months (range, 2-190 months). OCs
n 14 patients (32%) took place 5 years after EVAR. Ten
f these patients had had regular surveillance with detection
f and treatment for an endoleak(s) in eight; in four of
hese, endoleak appeared 5 years of follow-up.
The endografts that had been implanted were Ancure
Guidant, Menlo Park, Calif) in 16, Excluder (W. L. Gore
Associates, Flagstaff, Ariz) in 13, AneuRx (Medtronic,
anta Rosa, Calif) in eight, Zenith (Cook, Bloomington,
nd) in three, Renu (Cook) in one, and Lifepath (Edwards
ifesciences, Irvine, Calif) in one. The endografts were
ndetermined in two patients.
The index EVAR had been performed at UPMC in 34
atients, at VAPHS in four, and at another hospital in six.
uring the study period, 1549 EVARs were performed at
PMC and 133 at VAPHS. The estimated (considering
hose lost to follow-up as well as those whose EVAR was
erformed elsewhere) overall OC rate was 2.6% (2.6% at
PMC and 3.0% at VAPHS). The actual OC rates have
een relatively stable during the past 8 years, whereas the
bsolute number of OCs appears to have increased during
d nonelective open conversions
Elective Nonelective P
19 (43) 25 (57)
75 73 .66
16 (84) 18 (72) .47
17 (90) 23 (92) .99
11 (58) 14 (56) .99
5 (26) 4 (16) .47
9 (47) 14 (56) .76
5 (26) 7 (28) .99
2 (10) 4 (16) .68
4 (21) 3 (12) .44
5 (26) 8 (32) .75
10 (53) 14 (56) .29
13 (68) 17 (68) .99
11 (58) 11 (44) .54
isease.
iation.e an
nary dhe same period, as shown in Fig 1.
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June 20121564 Chaar et alThe mean diameter of the aneurysms was 62 16 mm
at the time of OC compared with 57 11 mm at the index
EVAR. All except one were done electively. The lone
nonelective EVAR was for a ruptured AAA (RAAA). A type
II endoleak emanating from a lumbar artery was detected
on computed tomography (CT) scan at the 1-month
follow-up. The patient presented 5 months later with local-
ized rupture related to a type Ib endoleak and was treated
with endovascular extension of the left iliac limb. He re-
turned 3 weeks later with sepsis secondary to an aortoen-
teric fistula and underwent complete explantation of an
Excluder endograft and reconstruction with an axillo-
bifemoral bypass. Six patients who underwent EVAR at our
institution failed to follow-up and underwent OC for rup-
ture (n 3) and symptomatic aneurysm expansion (n 3).
Indications
The indications for OC in the 44 patients were aneu-
rysm growth in 28 (64%), rupture in 12 (27%), and infec-
tion in four (9%; Table II); of these, 25 (57%) required an
urgent or emergency OC. There was no difference in
demographics or comorbidities between those who under-
went OC under elective vs nonelective settings (Table I).
All elective OCs were performed for asymptomatic aneu-
rysm sac expansion. The most common mechanism of
failure was type II endoleak in 18 (41%), followed by type I
endoleak in 15 (34%). A type I endoleak in five patients was
associated with endograft migration (three AneuRx, one
Fig 1. The number of open conversions (OC) performe
of total endovascular aneurysm repairs (EVARs) perform
OC/total number of EVARs.Ancure, and one Excluder). 1ndovascular reintervention before OC
Twenty-two patients (50%) had had a total of 32 endo-
ascular interventions during follow-up before requiring
C. The indications for reintervention were type II en-
oleak in 15, type I endoleak in 14, and types I and II
ndoleak in two. The endovascular reinterventions were
ot successful in treating the culprit lesion in 15 patients.
he reasons for failure included failure to identify the
esion, inaccessibility of high lumbar arteries, excessive iliac
ortuosity, and proximal neck dilatation preventing an ad-
quate seal. Reinterventions were successful in the remain-
ng seven patients; however, the patients presented with
nother endoleak or expansion without a clear etiology. Of
ote, 4 of 12 patients who presented with RAAA had a
istory of endovascular reinterventions.
perative techniques
Surgical approach. A transperitoneal approach was
sed in 98% of cases. Only one patient had a retroperitoneal
xposure. He had a partial explantation of a Renu endograft
or rupture.
Clamp site. Supraceliac aortic control was used in nine
atients, suprarenal in 20, and infrarenal in seven. Mean
enal ischemia time was 28  7 minutes. Aortic cross-
lamping was not used in eight patients who were treated
ith complete endograft preservation.
Endograft explantation with reconstruction. Com-
lete endograft explantation was ultimately performed in
r a decade. The OC rate was calculated as a percentage
uring a 2-year period as follows: OC rate  number ofd ove
ed d6 patients (36%): four had graft infections, of which three
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Volume 55, Number 6 Chaar et al 1565were due to aortoenteric fistulas, five patients presented
with RAAA, and seven had growing aneurysm sac.
An additional 18 patients were treated with partial
endograft explantation. The endograft components left
behind in 10 patients were most commonly the iliac stents
only. In five patients, the iliac limbs and the proximal aortic
struts or suprarenal stents were left behind. In two patients
the iliac limbs were completely removed, with the proximal
leading edge of the endograft left in situ. In the remaining
two patients, only an iliac limb was removed and surgically
replaced. The indications for intervention were rupture in
seven and aneurysm sac expansion in 11.
Reconstruction with an aortoiliac bifurcated graft was
the most common method, used in 23 patients, followed
by a tube graft in six. Three patients underwent axillo-
bifemoral bypass grafting for aortic infection, followed by
complete explantation and ligation of the aortic stump. In
one patient, the left iliac limb of the endograft was replaced
with an 8-mmDacron interposition graft. One patient who
presented with a rupture died in the operating room before
reconstruction could be attempted.
Complete endograft preservation. Ten patients
(23%) were treated with complete endograft preservation.
This was achieved by selective ligation of the culprit arteries
causing a type II endoleak: lumbar artery (n  4), inferior
mesenteric artery (n 5), and middle sacral artery (n 1).
One patient underwent proximal neck banding for a type Ia
endoleak related to a short, angulated neck with reverse
funnel configuration. The aneurysm sac was opened to
document absence of flow around the endograft. The wall
Table II. Operative data stratified by urgency, indication,
Urgency Elective
Indication Aneurysm growth (19)
Endograft
management
Explantation (12) Preservation (7) Exp
Endograft type Ancure (2) Ancure (4) Anc
AneuRx (3) AneuRx (1) Ane
Excluder (6) Excluder (1) Exc
Zenith (1) Lifepath (1) Zen
Time: EVAR to OC,
mean  SD,
months
50  29 46  29 46 
Prior endovascular
proceduresa
8 (11) 6 (9) 1 (2
Aortic clamp site Suprarenal (9) Supraceliac (2) Sup
Infrarenal (3) No clamping (5) Sup
Infr
Mechanism of
failureb
Type I EL (4) Type I EL (1) Typ
Type II EL (6) Type II EL (6) Typ
Type V EL (1)
Undetermined (1)
AEF, Aortoenteric fistula; EL, endoleak; OC, open conversion.
aNumber of patients (number of endovascular procedures).
bA patient may have more than one type of endoleak.of the aneurysm was imbricated to obliterate potential wpace around the endograft. He was well, without any
ubsequent graft-related complications, on a 14-month
ollow-up CT.
orbidity and mortality
The overall morbidity was 55%. The most common
omplication in the 44 patients was acute renal failure in 10
23%); followed by pneumonia in nine (20%); bleeding in
ine (20%); myocardial infarction, urinary tract infection,
ound infection, or Clostridium difficile colitis in two
atients (5%) each; and deep vein thrombosis or femoral
seudoaneurysm in one patient (2%) each. Only two pa-
ients (5%) required hemodialysis. The other complication
as a sigmoid perforation 16 days after partial explantation
f a Zenith endograft.
Intraoperative complications during OC occurred in
ix patients, including bowel injury, splenectomy, ureteral
njury, or thrombosis of lower extremity bypass graft in one
atient each, and bleeding in two patients. Eight patients
18%) required a return to the operating room, two for
leeding and one patient each for bowel ischemia, ureteral
njury, compartment syndrome, thrombosis, femoral pseu-
oaneurysm, or sigmoid perforation. The mean hospital
ength of stay was 13  11 days.
Operative mortality was 18% (8 of 44), including one
ntraoperative death (Table III). Table IV details the mor-
idity and mortality stratified according to the treatment
ndication and the technique used. There was a trend
oward higher morbidity with nonelective OCs compared
endograft management
Nonelective
neurysm growth (9) Rupture (12) Infection (4)
tion (6) Preservation (3) Explantation (12) Explantation (4)
1) Excluder (3) Ancure (7) Ancure (2)
(2) AneuRx (2) Excluder (2)
(1) Excluder (1)
) Renu (1)
Unknown (1)
43  31 47  54 21  22
1 (1) 4 (7) 2 (2)
ac (2) No clamping (3) Supraceliac (4) Supraceliac (1)
al (3) Suprarenal (5) Suprarenal (3)
l (1) Infrarenal (3)
L (5) Type II EL (3) Type I EL (6) AEF (3);
infection (1)
L (1) Type II EL (2)
Type III EL (2)
Undetermined (3)
AEF (1)and
A
lanta
ure (
uRx
luder
ith (2
39
)
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(32% vs 0%; P  .006).
Mortality rates did not differ significantly between the
elective (all of which were for aneurysm growth) and non-
elective (5% vs 28%; P .11) OC groups, but this was most
likely related to the small number of patients. When evalu-
ating for the indications of aneurysm growth and rupture,
the difference in mortality rates between elective and non-
elective OC for aneurysm growth or rupture closely ap-
proached statistical significance (5% [1 of 19] vs 29% [6 of
21]; P .05); it was significant, however, when deaths after
elective OC for aneurysm growth were compared with
those after OC for rupture (5% [1 of 19] vs 33% [4 of 12];
P  .038).
Two patients underwent attempted endograft preser-
vation but ultimately required graft explantation due to
Table III. Complications of patients with operative morta
Pt Indication Technique used EG type
1 Aneurysm growth Complete
explantation
AneuRx
2 Aneurysm growth Partial
explantation
Zenith
3 Rupture Complete
explantation
Ancure
4 Infection Complete
explantation
Ancure
5 Aneurysm growth Partial
explantation
AneuRx
6 Rupture Preservation Ancure
7 Rupture Partial
explantation
Renu
8 Rupture Intended complete
explantation
Excluder
ARF, Acute renal failure; DVT, deep vein thrombosis; EG, endograft; LE, l
Table IV. Morbidity, mortality, and survival stratified acco
Urgency Elective
Indication Aneurysm growth (19)
EG management Explantation (12) Preservation (7) Explant
Complications Bleeding (2) Bleeding (1) Pneum
Wound infection (1) Pneumonia (1) UTI (1
Pneumonia (2) LE thro
UTI (1) ARF (2
MI (1) Sigmoid
ARF (2) Return
C diff colitis (1)
Morbidity 67 (8) 14 (1) 5
Mortality 8 (1) 0 3
LOS, days 11  10 7  6 10
Survival, mon 24  22 30  23 23
ARF, Acute renal failure; C diff, Clostridium difficile; EG, endograft; HD, h
OR, operating room; PA, pseudoaneurysm; UTI, urinary tract infection.
aCategorical data are presented as (number) or percentage (number); contirecurrent ruptures. The details of these patients and the gone intraoperative death can be found in the Appendix
online only).
ong-term follow-up
Themean survival after OCwas 20 24months. Eight
atients died during follow-up. One patient had partial
xplantation of a Zenith endograft for expanding aneurysm
t age 90 years. He presented 20 months later with RAAA
nd was treated with bilateral iliac limb extensions to con-
rol distal type Ib endoleaks. He subsequently developed
neumonia, respiratory failure requiring a tracheostomy,
nd dialysis-dependent acute renal failure. He was finally
ransferred to hospice and died. Nine patients (20%) were
ost to follow-up and no information could be found in the
ocial Security Death Index. Only one patient died among
hose treated with endograft preservation for aneurysm
Complications
RF, thrombosis of leg requiring return to OR for LE bypass,
persistent sepsis
VT, return to OR for sigmoid perforation, ARF
RF requiring hemodialysis, pneumonia, return to OR for
abdominal compartment syndrome
RF, return to OR for attempted ureteral stent placement after
injury to the ureter
eumonia, ARF, severe Clostridium difficile colitis, persistent
sepsis
eumonia, return to OR for bleeding five times, small-bowel
injury, open abdomen closed with Vicryl mesh
hrombosis of bilateral LE bypass grafts requiring thrombectomy,
persistent post-op bleeding and sepsis
traoperative death due to hemorrhage
xtremity; OR operating room.
g to urgency, indication, and surgical techniquea
Nonelective
rysm growth (9) Rupture (12) Infection (4)
(6) Preservation (3) Explantation (12) Explantation (4)
2) None Bleeding (6) ARF (1)
Pneumonia (6) C diff colitis (1)
1) UTI (1) Return to OR (1)
Femoral PA (1)
(1) MI (1)
R (2) Wound infection (1)
ARF (5)
New HD (3)
Return to OR (5)
0 92 (11) 50 (2)
0 33 (4) 25 (1)
8  2 16  14 19  16
18  12 6  12 24  40
ialysis; LE, lower extremity; LOS, length of stay; MI, myocardial infarction;
data are mean  standard deviation.lity
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The remaining eight patients (80%) had complete follow-
up, with imaging of the aneurysm confirming stability.
Long-term survival was significantly higher after elective
compared with nonelective OC (Fig 2).
DISCUSSION
This is the largest series of delayed OCs after EVAR
reported in the literature and illustrates that OC of ante-
cedent EVAR is accompanied by high complication and
death rates, except for a select group of patients with
aneurysm expansion who undergo ligation of feeding arter-
ies for a type II endoleak with preservation of the endograft.
Elective OC also provides an improved late survival. That
one-third of OCs in this series took place 5 years after
EVAR underscores the necessity for lifelong surveillance in
these patients. Duplex imaging may substitute for CT if the
aneurysm sac is shrinking or stable to reduce radiation
exposure and contrast-induced nephrotoxicity.9,10 En-
doleaks may develop at any time, and no one is impervious
to late complications of EVAR. As use of EVAR and its
follow-up increase, the need for OC is likely to parallel the
trend and underscore the need for close surveillance and
timely OC when indicated.
The Achilles’ heel of EVAR is its relatively high reinter-
Fig 2. Kaplan-Meier estimate of survival after electivevention rate, which reached up to 28% after 8 years in the domparison of Endovascular Aneurysm Repair with Open
epair in Patients with Abdominal Aortic Aneurysm
EVAR-1) trial.11 Although most reinterventions were en-
ovascular, 4% underwent OC with a 20% mortality rate,
hich is consistent with the results of the current study as
ell as those of other contemporary series with mortality
ates of 17% to 25%.5,12 The outcomes are worse when OC
s required for an emergency situation, such as rupture. In
he present study, 12 patients presented with rupture and
nderwent OC, with a 33% mortality. This is not dissimilar
rom what has been reported in the literature. Mehta et al7
eported a 30-day mortality rate of 20% after OC in 15
atients with rupture. A Cleveland Clinic series reported a
7% mortality rate in six patients who presented with
upture.5 Cho et al13 showed that prior EVAR does not
rovide a survival advantage when the aneurysm ruptures.
This is in contrast to recent reports that suggested that
C after EVAR can be performed safely with low morbid-
ty and no mortality, irrespective of acuity.4,8 However,
ach study only had one patient who presented with rup-
ure, andmostOCswere elective. In the present study, only
3% of patients underwent elective OC, and the mortality
ate in that subgroup was 5%, comparable to the perioper-
tive mortality after primary elective open AAA repair.1,3 It
s evident that the literature on late OC after EVAR is
line) and nonelective (dashed line) open conversions.ifficult to interpret and the results are difficult to compare
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mechanisms of endograft failure and varying presentations
and indications for surgery. Nevertheless, nonelective OC
appears to significantly increase the risks of morbidity.
In this series the mortality rate was 22% (2 of 9) after
nonelective OC for aneurysm expansion, 28.6% (6 of 21)
after nonelective OC for aneurysm growth or rupture, and
33% for rupture. These compare unfavorably with 5% for
elective OC for aneurysm growth. This underscores the
need not only for close surveillance but also the importance
of timely OC for avoidance of nonelective conversion,
especially rupture. It is well known that an increased risk of
death is sustained even after successful repair of and dis-
charge after RAAA repair,14 and it was again noted in this
series after nonelective OC. Avoidance of nonelective OC,
hopefully with preservation of the endograft, is ideal to
ensure optimal outcomes.
Management of endograft at the time of OC is a
controversial subject. Late endograft removal may be tech-
nically challenging. The presence of barbs or hooks and/or
suprarenal stents; additional stent graft, cuffs, or coils
placed during secondary interventions; endograft-induced
inflammatory changes around the vena cava; and the left
renal vein and the iliac veins all elevate the complexity of the
operation. Complete explantation may not be possible due
to well-incorporated ends of endograft or may be hazard-
ous. Complete excision of endograft may leave the aortic or
arterial wall too thin and denuded, increasing the chance of
anastomotic bleeding. In such cases, it is recommended to
leave the well-incorporated endograft in place and to incor-
porate the adjacent arterial/aortic wall when suturing the
surgical graft to the endograft remnant to prevent any
subsequent type I endoleak.
Some investigators have advocated preservation of all
or part of the endograft at the time of late OC to reduce
morbidity and mortality rates.6,15-17 The results in the
present study support the notion of endograft preservation
in the setting of sac expansion. Complete endograft pres-
ervation was achieved in 10 patients with aneurysm expan-
sion in the present study without perioperative death and
no rupture on follow-up; however, attempted preservation
for RAAA in two patients was not fruitful.
It is intuitive that multiple attempts in the treatment of
RAAA are undesirable. They are invariably accompanied by
increased blood product transfusion requirements, in-
creased length of hospital stay, other complications, and
death. The two patients in the present study who presented
with rupture and were initially treated with complete en-
dograft preservation and ligation of back-bleeding arteries
had poor outcomes. Both were readmitted with bleeding
shortly after OC and eventually died. Exploration of pa-
tients with contained rupture likely makes identification of
sources of bleeding and endotension more difficult due to
hemodynamic disturbances that may mask type I or type II
endoleak at the time of exploration. That may explain how
the two patients with ruptures, who were treated with
complete endograft preservation, were readmitted with
rupture shortly after open ligation of back-bleeding arter- Aes. Therefore, we caution against using compete endograft
reservation in cases of rupture and would favor explanta-
ion of the endograft. All too often, the surgeons are given
nly one chance at it.
In the current study, although the actual rates of OC
fter EVAR have been relatively stable, the number of OCs
eems to have increased over the study period as ex-
ected.4,17 A tertiary referral center is more likely to witness
uch a trend, as we have. This trend is likely to continue
ecause of the rising number of EVARs being performed,
ntrinsically high reintervention rates after EVAR, longer
ollow-up, and the proportion of EVARs that are per-
ormed outside of instruction for use.18-20 Furthermore,
ith an increasing number of young patients aged between
0 and 64 years (the number doubled from 2001 to 2006)
eing treated by EVAR, the number of patients requiring
C for rupture and other endograft-related complications
ver a course of long-term follow-up is likely to contribute
o this trend.18
The decision for OC has to be made after considering
he entire clinical scenario such as the patient’s comorbidi-
ies, life expectancy, the indication for conversion, and the
xtent of the prospective OC (ie, complete explantation vs
umbar ligation vs banding). Furthermore, identifying pa-
ients who are likely to develop late complications requiring
C is difficult. Thus, it would be inadvisable to set hard
ules for OC. However, one should consider OC after
ailed endovascular interventions for continued yearly an-
urysm growth of 5 mm on two consecutive imaging
ssessments or 6 cm on minor axis measurement. Any
emonstrated or suspected type I endoleak should be
reated if an endovascular solution is exhausted.
Even though this study presents the largest series of
elayed OC after EVAR, the major limitations include the
nherent selection bias of retrospective data collection and
he relatively small number of patients, which hindered
pparent differences from reaching significance. The pa-
ients with OC are a heterogeneous group with respect to
ndications and surgical techniques, making statistical anal-
sis impossible after stratifying patients, as summarized in
ables II and IV. Furthermore, 20% of patients were lost to
ollow-up. This may underestimate late graft-related com-
lication and mortality rates.
ONCLUSIONS
Late OC for graft-related or aneurysm-related compli-
ations after EVAR is associated with significant morbidity
nd mortality rates except when electively treating aneu-
ysm expansion from an isolated type II endoleak with
igation of the feeding branches and preservation of the
ndograft. A strategy toward proper recognition of indica-
ions for OC and timely intervention is necessary to help
mprove both the short- and long-term outcomes of late
onversion.
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The intraoperative death occurred in an 82-year-old
man who had undergone endovascular aneurysm repair
(EVAR) at the age of 77 because he was deemed a prohib-
itive surgical candidate due to cardiac and pulmonary co-
morbidities. He had had three endovascular procedures for
type Ia endoleak and a persistently growing aneurysm dur-
ing a 5-year period before presenting with a ruptured
abdominal aortic aneurysm (AAA).
The first procedure involved placement of an aortic
cuff. In the second procedure, two Palmaz stents were used
with partial coverage of the left renal artery. Because of
persistent aneurysm growth, a chimney procedure was per-
formed in which two aortic cuffs and a stent graft were
placed into the left renal artery. The right renal artery,
which supplied an atrophic kidney, was covered.
The patient presented with rupture 3 months after the
last endovascular intervention. He had uncontrollable
bleeding in the operating room and arrested. The intention
of the surgeon was to completely explant the endograft; for
that reason, the patient was classified with the complete
explantation group. The other patients who died postop-
eratively had multiple complications and most required a
return to the operating room to treat specific complica-
tions, as summarized in Table III.
Two patients underwent attempted endograft preser-
vation but ultimately required graft explantation due to aecurrent ruptures. The first was a 72-year-old man who
resented with a rupture 30 months after the initial EVAR.
nitially, the right internal iliac artery was ligated through a
etroperitoneal approach. He presented again 1 month
ater with another rupture and underwent ligation of a
umbar artery and partial explantation of the right limb,
hich was replaced with a surgical graft. His postoperative
ourse was prolonged and complicated by pneumonia and
yocardial infarction; he needed a tracheostomy and a
ercutaneous feeding tube. He never fully recovered and
ied in a nursing home 7 months later.
The second patient was a 65-year-old man who pre-
ented 72 months after EVAR with a contained AAA
upture from a left iliac type I endoleak. He was first treated
y coil embolization and extension of the left limb to the
xternal iliac artery. Hewas discharged the next day, only to
eturn 5 days later with a recurrent rupture with hemody-
amic instability. He then underwent OC, during which a
umbar artery from within the aneurysm sac was ligated.
he entire endograft was preserved. He was discharged to
eturn home on postoperative day 13 but returned to the
mergency department 7 days later with yet another epi-
ode of rupture. He then underwent a partial explantation
f the endograft with aortoiliac reconstruction. This, how-
ver, was also complicated by further episodes of bleeding,
equiring multiple open and endovascular interventions,
nd he died of multiorgan system failure.
